Press release
Biologic Therapeutics Drugs Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
Biologic Therapeutics Drugs Market is estimated to reach at a CAGR of 10% during the forecast period 2024-2031.DataM Intelligence unveils its latest report on the "Biologic Therapeutics Drugs Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/biologic-therapeutics-drugs-market?sg
List of Top Key Player: Pfizer Inc., Novartis Global, Smith Medical, Concord Biotech, H. Lundbeck A/S, AstraZeneca, Merck & Co. Inc., GlaxoSmithKline plc, Aurobindo Pharma Ltd., and Retractable Technologies Inc.
USA - Industry Developments:
✅ Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion
October 9, 2025 - Aimed at strengthening its liver disease portfolio, Novo Nordisk plans to acquire Akero Therapeutics, pending U.S. approval of Akero's drug efruxifermin.
✅ Halozyme Therapeutics to buy Elektrofi for up to $900 million
October 1, 2025 - Halozyme Therapeutics has agreed to acquire Elektrofi to expand its drug delivery portfolio, with payments tied to product approvals.
Japan - Industry Developments:
✅ Alvotech announces marketing approval of three new biosimilars in Japan
September 22, 2025 - Alvotech, in partnership with Fuji Pharma, received approval for three biosimilars, expanding its presence in the Japanese market.
✅ Nippon Shinyaku and REGENXBIO enter exclusive partnership for gene therapies
January 14, 2025 - The companies partnered to develop RGX-121 and RGX-111 for mucopolysaccharidosis diseases in the U.S. and Asia.
South Korea - Industry Developments:
✅ Celltrion in talks to acquire Eli Lilly plant in U.S. for $504 million
August 8, 2025 - Celltrion is negotiating to purchase an Eli Lilly manufacturing facility in the U.S., marking its first U.S. acquisition.
✅ Samsung Biologics launches optimized manufacturing framework 'Exellens'
October 9, 2025 - Samsung Biologics introduced 'Exellens' to enhance biologics manufacturing efficiency.
Europe - Industry Developments:
✅ Roche commences tender offer for 89bio, Inc.
September 30, 2025 - Roche initiated a tender offer to acquire 89bio, Inc., a U.S.-based biopharmaceutical company.
✅ Asahi Kasei makes $1.1 billion bid for Swedish Calliditas Therapeutics
February 2024 - Asahi Kasei proposed a $1.1 billion acquisition of Calliditas Therapeutics to expand its immunology portfolio.
Forecast Projection:
The Global Biologic Therapeutics Drugs Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.
Market Intelligence Research Process:
The Biologic Therapeutics Drugs Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=biologic-therapeutics-drugs-market?sg
Key Segmentation:
By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Others)
By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others)
By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics)
By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Global Growth Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Biologic Therapeutics Drugs Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.
Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.
Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.
Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.
Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.
Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.
Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.
Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.
Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/biologic-therapeutics-drugs-market?sg
FAQ's
Q1: How fast is the Biologic Therapeutics Drugs Market expected to grow in the coming years?
A: The market is forecast to expand at a robust CAGR of 10% between 2024-2031, signaling strong global growth and investment potential.
Q2: Which regions are dominating the Biologic Therapeutics Drugs Market and which are fastest-growing?
A: North America region holds the largest market share global biologic therapeutics drugs market.
Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sg
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologic Therapeutics Drugs Market 2025 | Industry Developments, Future Growth, Share & Industry Insights here
News-ID: 4216318 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP

United States Urban Farming Market is Growing Fast | Industry, CAGR, and City Ag …
DataM Intelligence has published a new research report on "Urban Farming Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
The Urban Farming Market demonstrated steady growth, rising…

United States Industrial Water Reuse and Recycling Industry Sector Is the Next B …
DataM Intelligence has published a new research report on "Industrial Water Reuse and Recycling Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
The World Business Council for…

Liquid Crystal Polymer Market 2025 | Industry Developments, Future Growth, Share …
Liquid Crystal Polymer Market is expected to grow at a CAGR of 5.8% during the forecasting period 2024-2031.
DataM Intelligence unveils its latest report on the "Liquid Crystal Polymer Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning…

United States Eosinophilic Disorders Market to hit US$ 278 Million By 2031 | Lea …
Market Size and Forecast:
The Global Eosinophilic Disorders Market reached US$ 150 million in 2023 and is expected to reach US$ 278 million by 2031 growing with a CAGR of 7.1% during the forecast period 2024-2031.
The Eosinophilic Disorders Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…